We compared patterns of neuropsychiatric symptoms across 4 dementia types [Alzheimer disease (AD), vascular dementia (VAD), dementia with Lewy bodies (DLB), and Parkinson disease dementia], and 2 mixed groups (AD/VAD and AD/DLB) in sample of 2,963 individuals from the National Alzheimer's Coordinating Center Uniform Data Set between September 2005 and June 2008. We used confirmatory factor analysis to compare neuropsychiatric symptom severity ratings made by collateral sources on the Neuropsychiatric Inventory Questionnaire for people with Clinical Dementia Rating scores of 1 or higher. A 3-factor model of psychiatric symptoms (mood, psychotic, and frontal) was shared across all dementia types. Between-group comparisons revealed unique neuropsychiatric profiles by dementia type. The AD group had moderate levels of mood, psychotic, and frontal symptoms whereas VAD exhibited the highest levels and Parkinson disease dementia had the lowest levels. DLB and the mixed dementias had more complex symptom profiles. Depressed mood was the dominant symptom in people with mild diagnoses. Differing psychiatric symptom profiles provide useful information regarding the noncognitive symptoms of dementia.
D eclines in memory and attention are considered hallmark symptoms of Alzheimer disease (AD), but noncognitive symptoms such as changes in mood, personality, and other neuropsychiatric symptoms are also prevalent, 1-3 especially during later stages. [4] [5] [6] Epidemiologic studies of people with incident dementia universally report mood-related symptoms 7 (eg, apathy, depression, anxiety) with psychotic features second. In specialty clinics, patients with vascular dementia (VAD) have been reported to experience changes in mood and personality including increased apathy and irritability. 8, 9 Patients with dementia with Lewy bodies (DLB) often show rigidity, poor emotional control, apathy, hallucinations, delusions, and depression. [10] [11] [12] Similar symptoms are reported in Parkinson disease dementia (PDD). 11, 13 Although neuropsychiatric symptoms have been described within a variety of dementia types, few studies have compared patterns of symptoms between dementia types using a standardized instrument 8, 9, 14 and those have been limited in sample size and variety of dementia diagnoses. The current study applies a factor analytic model of the Neuropsychiatric Inventory Questionnaire (NPI-Q) 15, 16 to individuals with AD, VAD, DLB, PDD, combined diagnoses of AD and VAD (AD/VAD), as well as combined AD and DLB (AD/DLB) who participated in research at one of the national Alzheimer's Disease Centers (ADC) contributing to the National Alzheimer Coordinating Center's (NACC). Neuropsychiatric evaluation of dementia characterizes patterns of psychiatric symptoms and associates unique symptom patterns with specific neuropathological processes. The diagnostic breadth of the current sample allows us to identify unique profiles of symptoms with specific dementia types, including less prevalent or rarer dementias (eg, DLB) and blended dementias (eg, AD/VAD). Previous studies have used exploratory factor analysis to investigate how the items of the NPI questionnaire cluster together. 13, 14, 17, 18 Others have used latent class and mixture modeling procedures (more exploratory techniques) to identify unique patterns of symptoms in previously unidentified groups of dementia patients. 19 In contrast, we used confirmatory factor analysis to validate the diagnostic groups (previously established by NACC clinicians) and compare dementia types based on their factor scores. Factor scores have the desirable property of being more sensitive symptom summary scores than observed/raw scores.
We began with an empirically validated 3-factor model of neuropsychiatric symptoms that was established in patients with AD (mood, psychotic, and frontal symptom domains) by Frisoni et al. 17 We then tested whether this model could be extended across multiple non-AD dementia variants. Although other models of symptom clusters do exist, 13, 14, 17, 18 we chose the 3-factor model because its aggregation of symptoms is used most commonly in clinical practice. Our study characterizes unique patterns of neuropsychiatric symptoms displayed in each of these dementia types or mixed dementias. Because this modeling procedure used a preponderant number of patients with AD, these results should be interpreted as relative to the AD-referent group.
June 2008 (acquired November 2009). This data includes demographic information (Table 1) and clinical data collected for 2,963 individuals who had archival data for NPI-Q and Clinical Dementia Rating (CDR) score of 1 or higher (to ensure presence of neuropsychiatric symptoms). Individuals met the following clinical diagnostic criteria for primary diagnosis: AD (n=2474), DLB (n=151), VAD (n=85), PDD (n=74), AD/VAD (n=92; AD was primary diagnosis), and AD/DLB (n=87; AD was primary diagnosis). The AD and DLB groups contain only persons without other concurrent diagnoses. For VAD and PDD, we used primary diagnosis although they include cases that are not pure, that is, they may be of mixed diagnosis. Individuals in the AD group who were <60 years of age were excluded. Sample sizes for other mixed dementia diagnoses were too small for inclusion in these analyses (n's <50).
Procedures
Individual NACC ADC studies were approved by local human subjects committees. Written informed consent was obtained from all patients and/or collateral sources. AD diagnosis was based on National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association. 20 VAD was diagnosed according to National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria. 21 DLB was diagnosed according the criteria established by the DLB Consortium. 22 PDD was diagnosed per the criteria established by the Movement Disorders Society Scientific Issues Committee. 23 
Measures
Trained clinicians administered the NPI-Q to an informant knowledgeable about the patient's behavior. This measure assesses 10 behavioral disturbances that may occur in dementia and other neuropsychiatric disorders: delusions, hallucinations, dysphoria, anxiety, agitation/ aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity. We combined the presence and severity questions for each NPI-Q item. Thus, symptom severity was rescaled from 0 to 3, and treated as a ratio scaled index of the assessed symptom, 0 indicating no symptom present and 3 indicating severe symptomatology.
Statistical Analyses
Confirmatory Factor Analysis with full information maximum likelihood was conducted in a multistep process. 24 Step 1: to assess the relative fit of a 3-factor baseline model of psychiatric features in AD developed by Frisoni et al, 17 we collapsed across all dementia participants (n=2963) and examined domain content, factor loadings, and factor interrelationships ( Fig. 1 ). The 3-factors specified in this model are Mood (indicated by anxiety, apathy, and dysphoria items), Psychosis (irritability/lability, delusions, hallucinations, and agitation/aggression), and Frontal symptoms (euphoria and disinhibition).
Step 2: the baseline model was used in a series of increasingly restrictive between-group tests of invariance comparing 4 types of dementia (AD, VAD, DLB, and PDD) and % CDR 2  28  28  27  34  28  18  % CDR 3  11  13  11  15  12  12 AD/PDD mixed diagnosis was available but the sample was too small for inclusion in these analyses (n=45). AD indicates Alzheimer disease; CDR, Clinical Dementia Rating; DLB, dementia with Lewy bodies; PDD, Parkinson disease dementia; VAD, vascular dementia. Less constrained models must be accepted before subsequent higher order solutions can be interpreted. These tests indicate whether the psychometric properties of the instrument (factor structure and variance-covariance patterns) differ between the samples. The test of weak invariance is the least restrictive. Good fit indicates that the groups share the same factor structure and the same factor loadings. The test of strong invariance requires all assumptions for weak as well as the same test item intercepts across groups. No differences at strong invariance (equal factor loadings and item intercepts) indicate that the groups share similar psychometric configurations for the NPI-Q. Differences at strong invariance indicate the groups differ in the amount of the trait measured. This provides the analytic reasoning for Step 3, a between-group comparison on latent means using a test of latent mean invariance. Failure of a test of latent mean invariance suggests that groups differ in their mean levels of mood, psychotic, and frontal symptoms.
Step 4: if Step 3 fails to fit, we estimate how much these groups differ by constraining as many between-group coefficients to be equal as theoretically feasible and statistically warranted (model optimization). This yields a parsimonious model of between-group similarity and difference. 25 To evaluate model changes at each step of the analyses, we used goodness-of-fit indices as prescribed by Cheung and Rensvold. 26 In the first 2 steps, the psychometric properties of the model were evaluated using change in the Root Mean Square Error of Approximation (DRMSEA < À0.02). In the final 2 steps (between-group comparisons) we used change in À2 Log Likelihoods [Dw 2 (df=15) >7.3] to determine model fit.
RESULTS

Sample Characteristics
Dementia severity (CDR) did not differ between the groups (F=1.11, P=0.35; note all participants CDR Z1).
Omnibus tests for group differences in age, sex, and education were all significant (all F's >4.58, P<0.001). Bonferroni corrected pairwise comparisons revealed that the PDD and DLB groups were younger than all other groups (P<0.001) and contained far fewer women [w 2 (5)=107.5, P<0.001]; however, all other group comparisons were nonsignificant. Importantly, AD participants were statistically equivalent to all other dementia groups on age, sex, and education and thus were not controlled for in the modeling process. There was modest variation in level of education across the groups (range: 12.4 to 14.7), but only the 2 most extreme groups differed significantly (VAD vs. PDD).
Because dementia severity (CDR) affected symptom presentation ( Table 2) , all models reported here are adjusted for CDR status. Participants with more progressed AD reported more psychotic symptoms (b=0.23, P<0.001) and more frontal symptoms (b=0.10, P<0.01). For DLB, higher dementia severity predicted an increase in psychotic symptoms (b=0.30, P<0.01). For AD/VAD, higher dementia severity predicted increased mood symptoms (b=0.42, P<0.05) and psychotic symptoms (b=0.55, P<0.001). For AD/DLB, higher dementia severity predicted increased frontal symptoms (b=0.42, P<0.05). Disease severity did not predict the levels of any type of symptoms on the NPI in the PDD or VAD groups.
Step 1: We examined domain content, factor loadings, and factor interrelationships of the 3-factor model originally proposed by Frisoni et al 17 (Fig. 1) . The best fitting model was both similar to and different from the Frisoni model. Like Frisoni et al, we found that the aberrant motor activity item loaded highly on all 3factors (b's ranged from 0.34 to 0.51) and resulted increased model misfit (DRMSEA=+0.01). Thus, it was excluded from the baseline model. Unlike Frisoni et al, we found that the apathy item fit well in the baseline, thus it was included. Finally, delusions and hallucinations items covaried significantly (DRMSEA < À 0.02).
Step 2: Multiplegroup tests of invariance's were used to compare the different types of dementia ( Table 3 ). The tests of weak invariance (equivalent factor loadings) and strong invariance (equivalent factor loadings and item intercepts) indicated that the groups were statistically equivalent at these levels (neither DRMSEA > À0.02).
Step 3: The test for equal latent means failed [Dw 2 (15)=79.0, P<0.001] indicating that although the groups shared the same model configuration (3 latent domains made up by Mood, Psychosis, and Frontal symptom clusters), neuropsychiatric profiles varied by dementia type (Table 2) . Compared with the other 4 patient groups, AD participants scored in the moderate range across the symptom domains (Mood=0.78, Psychosis=0.52, and Frontal=0.25). Patients with VAD reported the highest symptom levels (Mood =0.90, Psychosis=0.60, and Frontal=0.36) and PDD reported the lowest (Mood=0.67, Psychosis=0.46, and Frontal=0.11).
Step 4: In the final optimized model (Fig. 2) , diagnoses clustered in 2 levels on the Mood symptom domain (VAD=AD/DLB=DLB>AD=AD/VAD=PDD), in 3 levels on the Psychosis symptom domain (VAD >AD=AD/DLB=DLB>AD/VAD=PDD), and in 3 levels on the Frontal symptom domain (VAD >AD/ VAD=AD=AD/DLB=DLB >PDD). Notably DLB and AD/DLB had identical patterns of factor means across all domains. AD/VAD had an identical pattern to AD on Mood and Frontal symptoms, but AD/VAD was lower than AD on Psychosis. Dementia types also shared similar correlation structures ( Table 2) between Mood and Frontal symptoms (r=0.38) and between Psychotic and Frontal symptoms (r=0.52). Thus the groups shared similar relationships among the least frequently occurring neuropsychiatric symptoms. The dementia types did differ significantly in how Mood and Psychotic symptoms correlated. In AD they correlated in the moderate range (r=0.62) and could not be equated to any of the other diagnosis groups. In the 2 mixed diagnoses and in DLB correlations were higher (r=0.80). Finally, VAD and PDD shared similar low correlations (r=0.32).
DISCUSSION
Using a large sample of mild-to-moderate staged people with dementia from the NACC database, this study compared the neuropsychiatric profiles of 4 common dementia types (AD, VAD, DLB, and PDD) and 2 mixed dementias (AD/VAD and AD/DLB). We found that dementia types shared many common symptoms and could be compared with 1 another along 3 psychiatric symptom domains (Mood, Psychosis, and Frontal). The 26 wThe optimized model equates all between-group factor means and correlations that are statistically warranted Figure 1 . CI indicates confidence interval; RMSEA, Root Mean Square Error of Approximation. group profiles differed in the severity and interrelatedness of the symptom domains. Participants with AD consistently reported moderate symptom severities, VAD the highest, and PDD the lowest (probably owing to their younger age and relative milder stage of disease). DLB and the mixed dementias reported more complex symptom profiles. Given that these DLB patients probably have concomitant ADtype changes it appears the multiple cooccurring neuropathologies are interactive in some way, resulting in more extensive psychiatric symptom complexes. Across dementia types, caregivers reported that the person with dementia experienced psychiatric symptoms like anxiety, dysphoria, and apathy (items that make up the Mood symptom domain) more frequently than symptoms like irritability, delusions, hallucinations, and agitation (Psychosis symptom domain). Note that visual hallucinations are part of the diagnostic criteria for DLB and were expected to be higher in this group. Euphoria and disinhibition (Frontal symptom domain) were the least likely to be endorsed.
These data indicate a consistent neuropsychiatric symptom profile (Mood >Psychosis >Frontal) across dementia types wherein depressed mood is a prominent feature in all. 1, 2, [7] [8] [9] 11, 13 Although each disease is the result of different underlying pathologies (or blends of pathologic processes), they all reflect the presence of major neurologic disease resulting in extensive cell death and brain atrophy. The trauma associated with these processes seems to yield a depressive tone similar to what is witnessed in postictal stroke patients and other brain trauma. 29 This is likely why the VAD and AD/VAD blend report such high rates of mood symptoms.
Lower levels of endorsement of Psychosis and Frontal symptom domains is likely owing to the mild and moderate stages of dementia patients tested. In this sample, people in the later stages of dementia reported more of the symptoms that make up the Frontal and Psychosis domains; increasing dementia severity (CDR) was related to more severe Frontal symptoms (AD) and more Psychosis symptoms in AD, DLB, AD/DLB, and AD/VAD. Dementia status (CDR) did not correlate with symptom severity in PDD and VAD. The PDD group did not have as many later stage individuals, were slightly younger, and did not suffer as many neuropsychiatric symptoms. This may have attenuated the correlations of disease severity with neuropsychiatric symptoms in the PDD group. There were adequate numbers of later stage VAD participants and this group endorsed the greatest symptom severity. Thus, dementia severity (CDR) had less impact on symptom presentation in VAD.
Profiles of the mixed dementias indicated that when AD is concomitant with VAD, the AD-like psychiatric features tend to dominate but that when AD is concomitant with DLB, DLB-like psychiatric features tend to dominate. Across the 3 domains measured, AD/VAD participants reported less severe symptoms than VAD alone and this was similar to AD participant reports. The profile differences between VAD and AD/VAD may account for mixed reports of symptoms in the literature, some reporting more severe depression and anxiety, 9, 30 others reporting equivalent symptoms in AD and VAD. 31 Both sets of observations may be true depending on the makeup of the patient group studied. DLB and AD/DLB had identical patterns of factor means, most starkly characterized by high levels of mood symptoms. The presence of simultaneous AD and DLB pathology may represent an additive effect where the 2 diseases together result in more significant manifestation of mood symptoms. 32 This is consistent with research reports that patients with DLB often experience apathy and depression. 11, 12 NACC participants are recruited and enrolled in a variety of ways across participating ADCs, thus this large dataset likely suffers from diagnostic inconsistencies. Specifically, NACC is a clinic-based convenience sample and its generalizability may be limited. This clinic-based sample likely overestimates true prevalence of AD in the geriatric population. Participating ADCs focus on AD diagnosis and recruitment, thus biasing the sample toward over inclusion of AD variants. For example, the PDD participants reported mild psychiatric symptoms given their dementia status. These participants differ from previous reports about the NPI-Q used in PDD. 13 Differences in when and how these participants present for evaluation may explain why this PDD group was unexpectedly low in reporting psychiatric symptoms. As a result, these PDD data may not generalize well to movement disorder clinics. Others have noted that caregivers' appreciation of psychiatric symptoms may outstrip their ability to judge accurately symptom presence and severity, resulting in relatively higher levels of variability witnessed in these types of data. 33 Despite of these modest limitations the results of this study show that the NPI-Q can be used effectively to assess many types of dementia, their neuropsychiatric symptom profiles have unique features, and these results are consistent with several other studies. 2, 11, 13, 34, 35 Although AD was overrepresented in these data because it is the most prevalent dementia type worldwide and the primary target of NACC participating ADC's, this pattern of results is not dependent on the large AD sample size. When analyses were repeated with a randomly selected AD subsample (N=300) and tested using bootstrapped confidence intervals, results were identical. Further, the other dementias reported here are of great clinical value because of their relative rarity and that they were tested with a standardized battery. Owing to the large sample size of the NACC database, this study offers unique advantages because it aggregates relatively understudied dementias. Thus, we could demonstrate that the Frisoni 3-factor model of the NPI-Q can be applied in a wide range of geriatric clinical settings to investigate patterns of neuropsychiatric symptom severity across many dementia types.
